| Potential role of patients’ CYP3A-status in clozapine pharmacokinetics K Tóth, G Csukly, D Sirok, A Belic, Á Kiss, E Háfra, M Déri, Á Menus, ... International Journal of Neuropsychopharmacology 20 (7), 529-537, 2017 | 44 | 2017 |
| Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype K Tóth, G Csukly, D Sirok, A Belic, Á Kiss, E Háfra, M Déri, Á Menus, ... International journal of neuropsychopharmacology 19 (12), pyw083, 2016 | 36 | 2016 |
| Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure Á Kiss, Á Menus, K Tóth, M Déri, D Sirok, E Gabri, A Belic, G Csukly, ... European archives of psychiatry and clinical neuroscience 270, 71-82, 2020 | 24 | 2020 |
| Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia Á Menus, Á Kiss, K Tóth, D Sirok, M Déri, F Fekete, G Csukly, K Monostory Scientific Reports 10 (1), 21283, 2020 | 14 | 2020 |
| CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients F Fekete, Á Menus, K Tóth, ÁF Kiss, A Minus, D Sirok, A Belič, Á Póti, ... Scientific Reports 13 (1), 18507, 2023 | 4 | 2023 |
